| Literature DB >> 33722902 |
Wei-Chia Tseng1, Ana J Johnson Escauriza1, Chon-Hwa Tsai-Morris2, Benjamin Feldman2, Ryan K Dale3, Christopher A Wassif1, Forbes D Porter1.
Abstract
Niemann-Pick disease type C (NPC) is a rare, fatal, neurodegenerative lysosomal disease caused by mutations of either NPC1 or NPC2. NPC2 is a soluble lysosomal protein that functions in coordination with NPC1 to efflux cholesterol from the lysosomal compartment. Mutations of either gene result in the accumulation of unesterified cholesterol and other lipids in the late endosome/lysosome, and reduction of cellular cholesterol bioavailability. Zygotic null npc2m/m zebrafish showed significant unesterified cholesterol accumulation at larval stages, a reduction in body size, and motor and balance defects in adulthood. However, the phenotype at embryonic stages was milder than expected, suggesting a possible role of maternal Npc2 in embryonic development. Maternal-zygotic npc2m/m zebrafish exhibited significant developmental defects, including defective otic vesicle development/absent otoliths, abnormal head/brain development, curved/twisted body axes and no circulating blood cells, and died by 72 hpf. RNA-seq analysis conducted on 30 hpf npc2+/m and MZnpc2m/m embryos revealed a significant reduction in the expression of notch3 and other downstream genes in the Notch signaling pathway, suggesting that impaired Notch3 signaling underlies aspects of the developmental defects observed in MZnpc2m/m zebrafish.Entities:
Keywords: Cholesterol; Niemann–Pick type C; Niemann–Pick type C2; Notch3; Npc2; Zebrafish
Mesh:
Substances:
Year: 2021 PMID: 33722902 PMCID: PMC8077516 DOI: 10.1242/dev.194258
Source DB: PubMed Journal: Development ISSN: 0950-1991 Impact factor: 6.868